1 Market Overview
1.1 Needle-Free Drug Delivery Systems Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Needle-Free Drug Delivery Systems Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Jet-Based
1.2.3 Spring-Based
1.2.4 Laser-Based
1.3 Market Analysis by Application
1.3.1 Overview: Global Needle-Free Drug Delivery Systems Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Needle-Free Drug Delivery Systems Market Size & Forecast
1.4.1 Global Needle-Free Drug Delivery Systems Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Needle-Free Drug Delivery Systems Sales in Volume (2017-2028)
1.4.3 Global Needle-Free Drug Delivery Systems Price (2017-2028)
1.5 Global Needle-Free Drug Delivery Systems Production Capacity Analysis
1.5.1 Global Needle-Free Drug Delivery Systems Total Production Capacity (2017-2028)
1.5.2 Global Needle-Free Drug Delivery Systems Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Needle-Free Drug Delivery Systems Market Drivers
1.6.2 Needle-Free Drug Delivery Systems Market Restraints
1.6.3 Needle-Free Drug Delivery Systems Trends Analysis
2 Manufacturers Profiles
2.1 Antares Pharma
2.1.1 Antares Pharma Details
2.1.2 Antares Pharma Major Business
2.1.3 Antares Pharma Needle-Free Drug Delivery Systems Product and Services
2.1.4 Antares Pharma Needle-Free Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Pharmajet
2.2.1 Pharmajet Details
2.2.2 Pharmajet Major Business
2.2.3 Pharmajet Needle-Free Drug Delivery Systems Product and Services
2.2.4 Pharmajet Needle-Free Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Optinose
2.3.1 Optinose Details
2.3.2 Optinose Major Business
2.3.3 Optinose Needle-Free Drug Delivery Systems Product and Services
2.3.4 Optinose Needle-Free Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Valeritas
2.4.1 Valeritas Details
2.4.2 Valeritas Major Business
2.4.3 Valeritas Needle-Free Drug Delivery Systems Product and Services
2.4.4 Valeritas Needle-Free Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Crossject
2.5.1 Crossject Details
2.5.2 Crossject Major Business
2.5.3 Crossject Needle-Free Drug Delivery Systems Product and Services
2.5.4 Crossject Needle-Free Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Injex Pharma
2.6.1 Injex Pharma Details
2.6.2 Injex Pharma Major Business
2.6.3 Injex Pharma Needle-Free Drug Delivery Systems Product and Services
2.6.4 Injex Pharma Needle-Free Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 3M Pharmaceuticals
2.7.1 3M Pharmaceuticals Details
2.7.2 3M Pharmaceuticals Major Business
2.7.3 3M Pharmaceuticals Needle-Free Drug Delivery Systems Product and Services
2.7.4 3M Pharmaceuticals Needle-Free Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Becton Dickinson (BD)
2.8.1 Becton Dickinson (BD) Details
2.8.2 Becton Dickinson (BD) Major Business
2.8.3 Becton Dickinson (BD) Needle-Free Drug Delivery Systems Product and Services
2.8.4 Becton Dickinson (BD) Needle-Free Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 MedImmune
2.9.1 MedImmune Details
2.9.2 MedImmune Major Business
2.9.3 MedImmune Needle-Free Drug Delivery Systems Product and Services
2.9.4 MedImmune Needle-Free Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Mystic Pharmaceuticals
2.10.1 Mystic Pharmaceuticals Details
2.10.2 Mystic Pharmaceuticals Major Business
2.10.3 Mystic Pharmaceuticals Needle-Free Drug Delivery Systems Product and Services
2.10.4 Mystic Pharmaceuticals Needle-Free Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Zogenix
2.11.1 Zogenix Details
2.11.2 Zogenix Major Business
2.11.3 Zogenix Needle-Free Drug Delivery Systems Product and Services
2.11.4 Zogenix Needle-Free Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Needle-Free Drug Delivery Systems Breakdown Data by Manufacturer
3.1 Global Needle-Free Drug Delivery Systems Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Needle-Free Drug Delivery Systems Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Needle-Free Drug Delivery Systems
3.4 Market Concentration Rate
3.4.1 Top 3 Needle-Free Drug Delivery Systems Manufacturer Market Share in 2021
3.4.2 Top 6 Needle-Free Drug Delivery Systems Manufacturer Market Share in 2021
3.5 Global Needle-Free Drug Delivery Systems Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Needle-Free Drug Delivery Systems Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Needle-Free Drug Delivery Systems Market Size by Region
4.1.1 Global Needle-Free Drug Delivery Systems Sales in Volume by Region (2017-2028)
4.1.2 Global Needle-Free Drug Delivery Systems Revenue by Region (2017-2028)
4.2 North America Needle-Free Drug Delivery Systems Revenue (2017-2028)
4.3 Europe Needle-Free Drug Delivery Systems Revenue (2017-2028)
4.4 Asia-Pacific Needle-Free Drug Delivery Systems Revenue (2017-2028)
4.5 South America Needle-Free Drug Delivery Systems Revenue (2017-2028)
4.6 Middle East and Africa Needle-Free Drug Delivery Systems Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Needle-Free Drug Delivery Systems Sales in Volume by Type (2017-2028)
5.2 Global Needle-Free Drug Delivery Systems Revenue by Type (2017-2028)
5.3 Global Needle-Free Drug Delivery Systems Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Needle-Free Drug Delivery Systems Sales in Volume by Application (2017-2028)
6.2 Global Needle-Free Drug Delivery Systems Revenue by Application (2017-2028)
6.3 Global Needle-Free Drug Delivery Systems Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Needle-Free Drug Delivery Systems Sales by Type (2017-2028)
7.2 North America Needle-Free Drug Delivery Systems Sales by Application (2017-2028)
7.3 North America Needle-Free Drug Delivery Systems Market Size by Country
7.3.1 North America Needle-Free Drug Delivery Systems Sales in Volume by Country (2017-2028)
7.3.2 North America Needle-Free Drug Delivery Systems Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Needle-Free Drug Delivery Systems Sales by Type (2017-2028)
8.2 Europe Needle-Free Drug Delivery Systems Sales by Application (2017-2028)
8.3 Europe Needle-Free Drug Delivery Systems Market Size by Country
8.3.1 Europe Needle-Free Drug Delivery Systems Sales in Volume by Country (2017-2028)
8.3.2 Europe Needle-Free Drug Delivery Systems Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Needle-Free Drug Delivery Systems Sales by Type (2017-2028)
9.2 Asia-Pacific Needle-Free Drug Delivery Systems Sales by Application (2017-2028)
9.3 Asia-Pacific Needle-Free Drug Delivery Systems Market Size by Region
9.3.1 Asia-Pacific Needle-Free Drug Delivery Systems Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Needle-Free Drug Delivery Systems Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Needle-Free Drug Delivery Systems Sales by Type (2017-2028)
10.2 South America Needle-Free Drug Delivery Systems Sales by Application (2017-2028)
10.3 South America Needle-Free Drug Delivery Systems Market Size by Country
10.3.1 South America Needle-Free Drug Delivery Systems Sales in Volume by Country (2017-2028)
10.3.2 South America Needle-Free Drug Delivery Systems Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Needle-Free Drug Delivery Systems Sales by Type (2017-2028)
11.2 Middle East & Africa Needle-Free Drug Delivery Systems Sales by Application (2017-2028)
11.3 Middle East & Africa Needle-Free Drug Delivery Systems Market Size by Country
11.3.1 Middle East & Africa Needle-Free Drug Delivery Systems Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Needle-Free Drug Delivery Systems Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Needle-Free Drug Delivery Systems and Key Manufacturers
12.2 Manufacturing Costs Percentage of Needle-Free Drug Delivery Systems
12.3 Needle-Free Drug Delivery Systems Production Process
12.4 Needle-Free Drug Delivery Systems Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Needle-Free Drug Delivery Systems Typical Distributors
13.3 Needle-Free Drug Delivery Systems Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
世界の無針ドラッグデリバリーシステム市場2022年：市場規模予測（～2028年） |
| 【英語タイトル】Global Needle-Free Drug Delivery Systems Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028 | |
 | ・商品コード：GIR22DC3555 ・発行会社（調査会社）：GlobalInfoResearch ・発行日：2023年1月 ・ページ数：103 ・レポート言語：英語 ・レポート形式：PDF ・納品方法：Eメール（注文後2-3日） ・調査対象地域：グローバル ・産業分野：医療機器 |
| Single User（1名様閲覧用） | USD3,480 ⇒換算￥528,960 | 見積依頼/購入/質問フォーム |
| Multi User（20名様閲覧用） | USD5,220 ⇒換算￥793,440 | 見積依頼/購入/質問フォーム |
| Corporate User（同一法人内共有可） | USD6,960 ⇒換算￥1,057,920 | 見積依頼/購入/質問フォーム |
|
※販売価格オプションの説明 ※お支払金額：換算金額（日本円）＋消費税 ※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡） ※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能） |
| 無針ドラッグデリバリーシステム市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 GlobalInfoResearchの最新の調査によると、世界の無針ドラッグデリバリーシステムの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 無針ドラッグデリバリーシステム市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメントは次をカバーします。 ・ジェット式、スプリング式、レーザー式 用途別セグメントは次のように区分されます。 ・病院、診療所、その他 世界の無針ドラッグデリバリーシステム市場の主要な市場プレーヤーは以下のとおりです。 ・Antares Pharma、Pharmajet、Optinose、Valeritas、Crossject、Injex Pharma、3M Pharmaceuticals、Becton Dickinson (BD)、MedImmune、Mystic Pharmaceuticals、Zogenix 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、無針ドラッグデリバリーシステム製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要な無針ドラッグデリバリーシステムメーカーの企業概要、2019年～2022年までの無針ドラッグデリバリーシステムの価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要な無針ドラッグデリバリーシステムメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2017年～2028年までの地域別無針ドラッグデリバリーシステムの販売量、売上、成長性を示しています。 ・第5、6章では、2017年～2028年までの無針ドラッグデリバリーシステムの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での無針ドラッグデリバリーシステム市場予測を収録しています。 ・第12章では、主要な原材料、主要なサプライヤー、および無針ドラッグデリバリーシステムの産業チェーンを掲載しています。 ・第13、14、15章では、無針ドラッグデリバリーシステムの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 - 無針ドラッグデリバリーシステムの概要 - 種類別分析（2017年vs2021年vs2028年）：ジェット式、スプリング式、レーザー式 - 用途別分析（2017年vs2021年vs2028年）：病院、診療所、その他 - 世界の無針ドラッグデリバリーシステム市場規模・予測 - 世界の無針ドラッグデリバリーシステム生産能力分析 - 市場の成長要因・阻害要因・動向 ・メーカー情報（企業概要、製品概要、販売量、価格、売上） - Antares Pharma、Pharmajet、Optinose、Valeritas、Crossject、Injex Pharma、3M Pharmaceuticals、Becton Dickinson (BD)、MedImmune、Mystic Pharmaceuticals、Zogenix ・メーカー別市場シェア・市場集中度 ・地域別市場分析2017年-2028年 ・種類別分析2017年-2028年：ジェット式、スプリング式、レーザー式 ・用途別分析2017年-2028年：病院、診療所、その他 ・無針ドラッグデリバリーシステムの北米市場 - 種類別市場規模2017年-2028年 - 用途別市場規模2017年-2028年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど ・無針ドラッグデリバリーシステムのヨーロッパ市場 - 種類別市場規模2017年-2028年 - 用途別市場規模2017年-2028年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど ・無針ドラッグデリバリーシステムのアジア市場 - 種類別市場規模2017年-2028年 - 用途別市場規模2017年-2028年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど ・無針ドラッグデリバリーシステムの南米市場 - 種類別市場規模2017年-2028年 - 用途別市場規模2017年-2028年 - 主要国別市場規模：ブラジル、アルゼンチンなど ・無針ドラッグデリバリーシステムの中東・アフリカ市場 - 種類別市場規模2017年-2028年 - 用途別市場規模2017年-2028年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Needle-Free Drug Delivery Systems market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Needle-Free Drug Delivery Systems market size is estimated to be worth US$ 9972.6 million in 2021 and is forecast to a readjusted size of USD 16670 million by 2028 with a CAGR of 7.6% during review period. Hospital accounting for % of the Needle-Free Drug Delivery Systems global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Jet-Based segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Needle-Free Drug Delivery Systems include Antares Pharma, Pharmajet, Optinose, Valeritas, and Crossject, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Needle-Free Drug Delivery Systems market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Jet-Based
Spring-Based
Laser-Based
Market segment by Application can be divided into
Hospital
Clinic
Others
The key market players for global Needle-Free Drug Delivery Systems market are listed below:
Antares Pharma
Pharmajet
Optinose
Valeritas
Crossject
Injex Pharma
3M Pharmaceuticals
Becton Dickinson (BD)
MedImmune
Mystic Pharmaceuticals
Zogenix
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Needle-Free Drug Delivery Systems product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Needle-Free Drug Delivery Systems, with price, sales, revenue and global market share of Needle-Free Drug Delivery Systems from 2019 to 2022.
Chapter 3, the Needle-Free Drug Delivery Systems competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Needle-Free Drug Delivery Systems breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Needle-Free Drug Delivery Systems market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Needle-Free Drug Delivery Systems.
Chapter 13, 14, and 15, to describe Needle-Free Drug Delivery Systems sales channel, distributors, customers, research findings and conclusion, appendix and data source.
❖ レポートの目次 ❖
| ★調査レポート[世界の無針ドラッグデリバリーシステム市場2022年：市場規模予測（～2028年）] (コード：GIR22DC3555)販売に関する免責事項を必ずご確認ください。 |
| ★調査レポート[世界の無針ドラッグデリバリーシステム市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせ |
